Best for PCOS
The best GLP‑1 medications for PCOS in 2026
Polycystic ovary syndrome — often involves insulin resistance and weight gain.
Most relevant drugs
Top-scored options for PCOS
Each score is our overall rating from the clinical rubric (effectiveness, safety, evidence, value). The left rule is color-keyed to the molecule.
8.8
/ 10
Zepbound
Tirzepatide
Read the full review →
8.7
/ 10
Mounjaro
Tirzepatide
Read the full review →
8.7
/ 10
Wegovy
Semaglutide
Read the full review →
8.5
/ 10
Ozempic
Semaglutide
Read the full review →
Molecule key: Semaglutide Tirzepatide Oral Other GLP-1
Full ranking
Every GLP-1 we rank for PCOS
- Top pick1Editor's Choice
FDA-approved tirzepatide for weight loss
- Highest reported weight loss of any approved GLP-1 (avg ~21% in SURMOUNT-1)
- Dual GIP + GLP-1 mechanism
- FDA-approved for OSA + obesity (2024)
FDA-approvedBrand-nameOnce-weekly injectionDual GIP / GLP-1Insurance eligible8.8/10Editorial scoreiEditorial score — our drug ranking, weighted for clinical outcome (effectiveness and safety lead). Telehealth services also carry a separate Service scorecard (shown on the services pages), so the same brand can show a different number there.See reviewTrue cost · maint.$549/mo · 10mg+$150 - 2Runner-up
Tirzepatide for type 2 diabetes
- Significant A1C reduction
- Substantial weight loss as side benefit
Off-label useOnce-weekly injectionDual GIP / GLP-1Insurance eligible8.7/10Editorial scoreiEditorial score — our drug ranking, weighted for clinical outcome (effectiveness and safety lead). Telehealth services also carry a separate Service scorecard (shown on the services pages), so the same brand can show a different number there.See reviewTrue cost · maint.$549/mo · 7.5mg+$150 - 3Best for editor's choice#1· Editor's ChoiceEditor's ChoiceBest for CV Risk
FDA-approved semaglutide for chronic weight management
- Average 15% weight loss in clinical trials (STEP 1)
- FDA-approved with extensive safety record
- Weekly dosing
FDA-approvedBrand-nameOnce-weekly injectionGLP-1 receptor agonistInsurance eligibleMost transparent pricing8.7/10Editorial scoreiEditorial score — our drug ranking, weighted for clinical outcome (effectiveness and safety lead). Telehealth services also carry a separate Service scorecard (shown on the services pages), so the same brand can show a different number there.See reviewTrue cost · maint.$499/mo · 2.4mg - 4
Semaglutide approved for type 2 diabetes
- Strong A1C reduction in T2D
- Often covered by insurance for diabetes indication
Off-label useOnce-weekly injectionGLP-1 receptor agonistInsurance eligible8.5/10Editorial scoreiEditorial score — our drug ranking, weighted for clinical outcome (effectiveness and safety lead). Telehealth services also carry a separate Service scorecard (shown on the services pages), so the same brand can show a different number there.See reviewTrue cost · maint.$499/mo · 1mg
Quick comparison
Verified Jul 17, 2026| # | Product | Active ingredient | Starting price | True cost · maint. | FDA status | Score | |
|---|---|---|---|---|---|---|---|
| 1 | Zepbound | Tirzepatide | $1349/mo | $549/mo · 10mg+$150 | approved | Top ·8.8 | View → |
| 2 | Mounjaro | Tirzepatide | $1349/mo | $549/mo · 7.5mg+$150 | off-label | 8.7 | View → |
| 3 | Wegovy Most transparent pricing | Semaglutide | $1349/mo | Best ·$499/mo · 2.4mg | approved | 8.7 | View → |
| 4 | Ozempic | Semaglutide | Best ·$997/mo | Best ·$499/mo · 1mg | off-label | 8.5 | View → |
Summary
Our recommendations for PCOS
A short read of who wins for which kind of patient.
Recommendation labels are computed from each product’s editorial badges + scoring rubric. See methodology for the full rubric — page /best-glp1-for/pcos.
Evidence
What the trials show
Multiple small RCTs and observational studies show 5-10% weight reduction in PCOS patients on semaglutide or tirzepatide, with improved HOMA-IR (insulin sensitivity) and modest reductions in free testosterone. Cycle regularity improves in 40-60% of patients within 6 months. No GLP-1 has an FDA on-label PCOS indication yet, but evidence is strong enough that endocrinology and OB/GYN societies are discussing guideline updates.
Prescribing
How prescribers handle it
Most PCOS prescriptions are off-label using a weight-loss or T2D pathway. If you have BMI ≥ 30, Wegovy or Zepbound is straightforward. If BMI is 27-30 with insulin resistance, the indication is murkier; some prescribers code metabolic syndrome.
Insurance
How coverage works
PA approval depends on the coding pathway, not PCOS itself. BMI-based weight-loss PAs succeed; PCOS-only PAs do not. NovoCare and LillyDirect cash-pay channels work regardless of insurance coverage.
Cautions
GLP-1s during conception attempts are not recommended. Stop at least 2 months before trying to conceive due to limited safety data in pregnancy. Birth control effectiveness may transiently decrease during initial GI side effects (delayed absorption).
Editorial verdict
What we recommend
For overweight PCOS patients without contraindications, the metabolic case for GLP-1 use is among the strongest off-label applications in the category. Get a BMI-based PA pathway and treat PCOS improvement as the secondary benefit. The on-label PCOS approval is likely in the 2027-2028 timeframe.
Frequently asked questions
Which GLP-1 is best for PCOS?+
Our #1 pick is Zepbound. It scored highest on effectiveness and safety for PCOS based on our clinical rubric.
What does the evidence show for GLP-1 medications and PCOS?+
Multiple small RCTs and observational studies show 5-10% weight reduction in PCOS patients on semaglutide or tirzepatide, with improved HOMA-IR (insulin sensitivity) and modest reductions in free testosterone. Cycle regularity improves in 40-60% of patients within 6 months. No GLP-1 has an FDA on-label PCOS indication yet, but evidence is strong enough that endocrinology and OB/GYN societies are discussing guideline updates.
Does insurance cover GLP-1 medications for PCOS?+
PA approval depends on the coding pathway, not PCOS itself. BMI-based weight-loss PAs succeed; PCOS-only PAs do not. NovoCare and LillyDirect cash-pay channels work regardless of insurance coverage.
Are GLP-1 medications safe for PCOS?+
GLP-1s during conception attempts are not recommended. Stop at least 2 months before trying to conceive due to limited safety data in pregnancy. Birth control effectiveness may transiently decrease during initial GI side effects (delayed absorption).
The bottom line
Best GLP-1 for PCOS
For overweight PCOS patients without contraindications, the metabolic case for GLP-1 use is among the strongest off-label applications in the category. Get a BMI-based PA pathway and treat PCOS improvement as the secondary benefit. The on-label PCOS approval is likely in the 2027-2028 timeframe.